1. Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies

Jaleh Barar* , Yadollah Omidi*

Bioimpacts. 2015;5(2): 65-69. doi: 10.15171/bi.2015.18

PMCID: PMC4492186 PMID: 26191499 Scopus ID: 84930410369

Article

PDF

XML

Cited By:

Original Research

2. CFP10–loaded PLGA nanoparticles as a booster vaccine confer protective immunity against Mycobacterium bovis

Zhengmin Liang , Miaoxuan Li, Jiamin Ni, Tariq Hussain, Jiao Yao, Yinjuan Song, Yiduo Liu, Haoran Wang, Xiangmei Zhou*

BioImpacts. 2022;12(5): 395-404. doi: 10.34172/bi.2022.23645

PMCID: PMC9596879 PMID: 36381632 Scopus ID: 85140257880

Article

PDF

Full Text

XML

Cited By:

CFP10-NPs significantly enhanced the secretion of TNF-α and IL-1β in J774A.1 macrophages. Mucosal immunization with CFP10-NPs significantly increased the levels of TNF-α, IL-1β, IgA and CFP10-specific IFN-γ, and decreased bacterial load in lungs and spleen of M. bovis-infected mice.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons